How improved collaboration is increasing clinical trial productivity and performance

Drug development is a complex race. The complexity comes from the need for good science to bring credible safety and efficacy data for regulatory approval. The race is to achieve this as quickly as possible without compromising those fundamentals. There are many strategies that sponsors, CROs and sites employ to win this race, but anything that can positively impact the recruitment and retention of participants, regularly cited as the most impactful cause of delay, will help.